Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1400 Views
-
Last post by frodo
-
- 0 Replies
- 1041 Views
-
Last post by frodo
-
- 0 Replies
- 2789 Views
-
Last post by NHE
-
- 0 Replies
- 1355 Views
-
Last post by frodo
-
- 0 Replies
- 1395 Views
-
Last post by frodo
-
- 0 Replies
- 1322 Views
-
Last post by frodo
-
- 0 Replies
- 1712 Views
-
Last post by NHE
-
- 0 Replies
- 619 Views
-
Last post by NHE
-
- 1 Replies
- 3322 Views
-
Last post by Tif